ID 150 (Ibandronate Sodium 150 mg)
Pill with imprint ID 150 is Yellow, Capsule-shape and has been identified as Ibandronate sodium 150 mg. It is supplied by Alvogen Inc.
Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ID 150
Ibandronate sodium
- Imprint:
- ID 150
- Strength:
- 150 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Alvogen Inc
- National Drug Code (NDC):
- 47781-0103
More about ibandronate
- Ibandronate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 42 Reviews – Add your own review/rating
- Drug class: bisphosphonates
Consumer resources
- Ibandronate oral/injection
- Ibandronate Tablets
- Ibandronate Injection
- Ibandronate Intravenous (Advanced Reading)
- Ibandronate Oral, Injection (Advanced Reading)
Other brands: Boniva
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
